DUBLIN--(BUSINESS WIRE)--
Research and Markets has announced the addition of the "Brain Hemorrhage - Pipeline Review, H2 2016" report to their offering.
The Pharmaceutical and Healthcare latest pipeline guide Brain Hemorrhage - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Brain Hemorrhage (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Brain Hemorrhage (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Brain Hemorrhage and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 5, 5 and 1 respectively. Brain Hemorrhage.
Brain Hemorrhage (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/k366j3/brain_hemorrhage

View source version on businesswire.com: http://www.businesswire.com/news/home/20161209005407/en/